Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2015-06-05 4 AS $122.32 $228,001 D/D (1,864) 72,846 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-08-26 4 AS $95.06 $1,425,924 D/D (15,000) 113,878 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2016-11-25 4 AS $87.40 $1,310,988 D/D (15,000) 113,878 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-02-24 4 AS $87.99 $1,319,850 D/D (15,000) 128,442 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-16 4 AS $90.00 $1,295,730 D/D (14,397) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-06-19 4 AS $90.00 $54,270 D/D (603) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-09-15 4 AS $90.50 $1,357,500 D/D (15,000) 136,422 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-01-02 4 AS $89.23 $1,338,401 D/D (15,000) 133,976 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 AS $80.12 $801,200 D/D (10,000) 156,676 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-06-14 4 AS $90.00 $2,790,085 D/D (31,000) 155,167 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-04 4 AS $95.00 $208,620 D/D (2,196) 142,504 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-18 4 AS $94.09 $902,982 D/D (9,597) 136,304 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-25 4 AS $87.86 $521,186 D/D (5,932) 124,536 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-04-20 4 AS $90.00 $1,549,170 D/D (17,213) 122,656 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-04-24 4 AS $95.34 $1,917,617 D/D (20,000) 102,656 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-07-13 4 AS $130.00 $2,991,430 D/D (23,011) 102,995 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-07-20 4 AS $130.00 $16,430,570 D/D (126,389) 102,995 0 -
MRTX Mirati Therapeutics, Inc.   –       •      –    2020-08-10 4 AS $127.52 $1,313,783 D/D (10,000) 2,000 0 %
MRTX Mirati Therapeutics, Inc.   –       •      –    2020-12-15 4 AS $230.19 $2,333,907 D/D (10,000) 2,000 0 %
MRTX Mirati Therapeutics, Inc.   –       •      –    2022-02-11 4 AS $104.76 $1,161,717 D/D (11,000) 6,021 0 %
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-03-31 4 D $29.03 $34,604 D/D (1,192) 14,016 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-12 5 D $0.00 $0 D/D (1,101) 46,497 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2012-06-19 4 D $32.00 $333,312 D/D (10,416) 0 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-03-01 4 D $59.61 $113,736 D/D (1,908) 44,589 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2013-05-08 4 D $65.32 $204,517 D/D (3,131) 42,374 0 -
  294  Records found
  1   2   3   4   5   6  7   8   9   10   11   12      
  Page 6 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us